Heat-activated intravenous liposomal doxorubicin combined with mitomycin C hyperthermic intravesical chemotherapy (HIVEC) for treatment of bladder cancer
Authors
John W. Karanian (ORCID: https://orcid.org/0000-0002-0574-4231)
Bradford J. Wood (ORCID: https://orcid.org/0000-0002-4297-0051)
William D. Richardson (ORCID: https://orcid.org/0000-0001-7261-2485)
Charles Hesswani (ORCID: https://orcid.org/0000-0002-7391-5004)
Heat-activated intravenous liposomal doxorubicin combined with mitomycin C hyperthermic intravesical chemotherapy (HIVEC) for treatment of bladder cancer
John W. Karanian, Bradford J. Wood, William D. Richardson, Charles Hesswani et al.
Journal
International Journal of Hyperthermia
Topics
Bladder and Urothelial Cancer Treatments
article
Heat-activated intravenous liposomal doxorubicin combined with mitomycin C hyperthermic intravesical chemotherapy (HIVEC) for treatment of bladder cancer
John W. Karanian, Bradford J. Wood, William D. Richardson, Charles Hesswani, Ivane Bakhutashvili, W. Pritchard, Nikhil Gopal, Matthew F. Starost, Vladimir Valera, A. Mikhail, Sandeep Gurram, Keith T. Schmidt, Cody J. Peer, William D. Figg, Dieter Haemmerich
article en
Abstract
No abstract available for this paper.
Publication Tag
International Journal of HyperthermiaVol. 43(1)
Institutions
National Institutes of Health (US), Medical University of South Carolina (US), Office of Research Services (US), National Institutes of Health Clinical Center (US)